Literature DB >> 28084092

Mortality and extent of coronary artery disease in 2776 patients with type 1 diabetes undergoing coronary angiography: A nationwide study.

V Ritsinger1,2, C Hero3, A M Svensson4, N Saleh1, B Lagerqvist5, K Eeg-Olofsson3, A Norhammar1,6.   

Abstract

Background In a modern perspective there is limited information on mortality by affected coronary vessels assessed by coronary angiography in patients with type 1 diabetes. The aim of the present study was to characterise distribution of coronary artery disease and impact on long-term mortality in patients with type 1 diabetes undergoing coronary angiography. Design The design of this research was a nationwide population-based cohort study. Methods Individuals ( n = 2776) with type 1 diabetes undergoing coronary angiography 2001-2013 included in the Swedish National Diabetes Registry and Swedish Coronary Angiography and Angioplasty Registry were followed for mortality until 31 December 2013 (mean 7.1 years). In 79% the indication was stable or acute coronary artery disease. Coronary artery disease was categorised into normal (21%), one- (23%), two- (18%), three- (29%) and left main-vessel disease (8%). Results Mean age was 57 years and 58% were male. Mean diabetes duration was 35 years, glycated haemoglobin was 67 mmol/mol and 44% had normal or one-vessel disease. In multivariate Cox proportional analyses hazard ratio for mortality compared with normal findings was 1.09 (95% confidence interval 0.80-1.48) for one, 1.43 (1.05-1.94) for two, 1.47 (1.10-1.96) for three and 1.90 (1.35-2.68) for left main-vessel disease. Renal failure 2.29 (1.77-2.96) and previous heart failure 1.76 (1.46-2.13) were highly associated with mortality. Standard mortality ratio the first year was 5.55 (4.65-6.56) and decreased to 2.80 (2.18-3.54) after five years. Conclusions In patients with type 1 diabetes referred for coronary angiography mortality is influenced by numbers of affected coronary vessels. The overall mortality rate was higher compared with the general population. These results support early intensive prevention of coronary artery disease in this population.

Entities:  

Keywords:  Type 1 diabetes; coronary angiography; coronary artery disease; long-term outcome; mortality; registry

Mesh:

Year:  2017        PMID: 28084092     DOI: 10.1177/2047487316687860

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  3 in total

1.  Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006-2014.

Authors:  David Nathanson; Ugne Sabale; Jan W Eriksson; Thomas Nyström; Anna Norhammar; Urban Olsson; Johan Bodegård
Journal:  Pharmacoecon Open       Date:  2018-12

2.  Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction.

Authors:  Marco Trevisan; Edouard L Fu; Karolina Szummer; Anna Norhammar; Pia Lundman; Christoph Wanner; Arvid Sjölander; Tomas Jernberg; Juan Jesus Carrero
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-03-15

3.  Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction.

Authors:  Anne M Kerola; Anne Grete Semb; Markus Juonala; Antti Palomäki; Päivi Rautava; Ville Kytö
Journal:  Cardiovasc Diabetol       Date:  2022-09-06       Impact factor: 8.949

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.